In this study, we have shown that receptor-targeted liposome-peptide-siRNA nanoparticles represent a safe and efficient siRNA delivery system that could be used to prolong bleb survival and to prevent conjunctival fibrosis after glaucoma filtration surgery by targeting the MRTF-B gene as well as other potential gene targets associated with fibrosis. Here, MRTFB is linked to glaucoma.